Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  dipyridamole
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-22 of 22 for your search:
Start Over
Phase III Study of L-PAM vs P-32 and Persantine plus Aspirin vs Placebo for Thrombocytic Myeloproliferative Disorders
Phase: Phase III
Type: Treatment
Status: Closed
Age: 30 and over
Sponsor:
Protocol IDs: PVSG-10
Phase I/II Study of FLAP (5-FU/LV/AZT/DP) in Patients with Metastatic Colorectal Adenocarcinoma
Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: BRMP-8916C, NCI-90-C-45C, NCI-T89-0135N, T89-0135
Phase I/II Study of 14-Day Continuous Infusions of 5-FU/CF with Oral DP in Patients with Advanced Gastrointestinal and Breast Cancer
Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 20 to 80
Sponsor:
Protocol IDs: TCC-5290, NCI-V91-0020
S9700 Combination Chemotherapy in Treating Patients With Stage II or Stage III Pancreatic Cancer
Phase: Phase II
Type: Treatment
Status: Completed
Age: Not specified
Sponsor: NCI, Other
Protocol IDs: CDR0000065599, S9700, U10CA032102, SWOG-S9700, NCT00003018
Phase II Chemotherapy with MTX/DP in the Treatment of Patients with Metastatic, Locally Recurrent, or Unresectable Colorectal Cancer
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor:
Protocol IDs: NYU-8505, NCI-V86-0002
Phase II Chemotherapy with DP/MTX/HU/ARA-C in Patients with Advanced Hodgkin's Disease or non-Hodgkin's Lymphoma
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor:
Protocol IDs: MRH-860207, UCCRC-4586, NCI-V86-0102
Phase II Study of Chemotherapy with PALA plus Dipyridamole (Persantine) in Patients with Advanced Soft Tissue Sarcoma
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: MSKCC-876, NCI-T86-0200D, T86-0200
Phase II Chemotherapy with PALA plus Oral Dipyridamole in Patients with Metastatic non-Small Cell Lung Cancer (Summary Last Modified 10/88)
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: PURDUE-T87-0046, NCI-T87-0046D, T87-0046
Phase II Study of VBL/Dipyridamole in Patients with Locally Unresectable or Metastatic Renal Cell Adenocarcinoma (Summary Last Modified 12/89)
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: HOG-GU88-1, NCI-V89-0242
Phase II Study of VP-16 plus Chemotherapy Resistance Modulators in the Treatment of VP-16-Resistant Malignancies
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor:
Protocol IDs: CAN-OTT-9008, NCI-V91-0084
Phase II Trial of 5-FU/CF/DP in Patients with Advanced Colorectal Adenocarcinoma
Phase: Phase II
Type: Treatment
Status: Closed
Age: 16 and over
Sponsor: NCI
Protocol IDs: MDA-DM-93013, NCI-T93-0011D, T93-0011
Phase II Study of Continuous-Infusion 5-FU/CF/MITO with Oral Dipyridamole in Patients with Advanced, Measurable Pancreatic Cancer
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCCTG-924352, NCCTG-92-43-52
Phase I Study of Biochemical Modulation of Carboplatin/Etoposide by Dipyridamole/Prochlorperazine/Cyclosporine in Advanced or Refractory Cancer (Summary Last Modified 07/97)
Phase: Phase I
Type: Treatment
Status: Closed
Age: 18 to physiologic 70
Sponsor: NCI
Protocol IDs: CHNMC-IRB-91149, NCI-V96-1029
Phase I Study of PALA and Dipyridamole in Patients with Cancer
Phase: Phase I
Type: Treatment
Status: Closed
Age: over 18
Sponsor: NCI
Protocol IDs: UCSD-82510, NCI-T83-0922W, T83-0922
Phase I Evaluation of Acivicin and Dipyridamole Administered by Concurrent Intravenous Infusion
Phase: Phase I
Type: Treatment
Status: Closed
Age: over 18
Sponsor: NCI
Protocol IDs: WCCC-CO-8393, NCI-T83-1068W, T83-1068
Phase I Chemotherapy with DP/MTX in Patients with Advanced Malignant Disease
Phase: Phase I
Type: Treatment
Status: Closed
Age: over 18
Sponsor:
Protocol IDs: NYU-8501, NCI-V86-0009
Phase I Chemotherapy with 5-FU/Dipyridamole Administered by Concurrent Intravenous Infusion in Patients with Uncontrolled Cancer (Summary Last Modified 10/87)
Phase: Phase I
Type: Treatment
Status: Closed
Age: over 18
Sponsor: NCI
Protocol IDs: WCCC-CO-8694, NCI-T86-0114W, T86-0114
Phase I Study of Concurrent Intravenous Infusion of 5-FU plus Leucovorin and Dipyridamole in Adults with Uncontrolled Malignancies
Phase: Phase I
Type: Treatment
Status: Completed
Age: over 18
Sponsor: NCI
Protocol IDs: WCCC-CO-8836, NCI-T89-0012C, T89-0012
Phase I Sequential, Randomized, Dose-Finding Study of PALA/5-FU with vs without Dipyridamole in Patients with Metastatic Cancers (Summary Last Modified 05/92)
Phase: Phase I
Type: Treatment
Status: Completed
Age: any age
Sponsor: NCI
Protocol IDs: BGSM-99190, NCI-T90-0076D, T90-0076
Phlebotomy plus P-32 vs Phlebotomy plus Antiaggregating Therapy for Polycythemia Vera
Phase: No phase specified
Type: Treatment
Status: Closed
Age: 21 and over
Sponsor:
Protocol IDs: PVSG-5
Start Over